Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction
2011
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
2006
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
2006
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
2002 Standout
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial
2010
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel
2007
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
2011
Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina
2002
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)
2006
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
2007
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
1999
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2007
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
2006
Correlates of procedural complicationsand a simple integer risk scorefor percutaneous coronary intervention
2002
Variability in Individual Responsiveness to Clopidogrel
2007
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
2001
Takotsubo cardiomyopathy: State-of-the-art review
2009
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
2008
The current status and future direction of percutaneous coronary intervention without on‐site surgical backup: An expert consensus document from the Society for Cardiovascular Angiography and Interventions
2007
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
2007
The changing landscape of atherosclerosis
2021 StandoutNature
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
2009
Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
1999
The Year in Non-ST-Segment Elevation Acute Coronary Syndromes
2005
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
2010
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2008
Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults
1999
Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
2008
A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up
2009
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
2010
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction
2011
Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults
2000
Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
2009
Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization?
2010
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
2006
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Nonemergent coronary angioplasty without on-site surgical backup: A randomized study evaluating outcomes in low-risk patients
2006
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (from the ACC-National Cardiovascular Data Registry)
2003
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery
2006
Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction
2008 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook
2015
A Randomized Clinical Study Comparing Double Kissing Crush With Provisional Stenting for Treatment of Coronary Bifurcation Lesions
2011
Targeting proteinase-activated receptors: therapeutic potential and challenges
2012
Guidelines for Percutaneous Coronary Interventions
2005
Meta-Analysis of Randomized Trials of Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus
2007
Prolongation of the QT Interval and the Sudden Infant Death Syndrome
1998
Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement
2006
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
2009
Clopidogrel Loading Dose (300 Versus 600 mg) Strategies for Patients With Stable Angina Pectoris Subjected to Percutaneous Coronary Intervention
2006
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
2006
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
2008
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
2010
Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions
2004
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
2006
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
2012
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
2005
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention
2008
Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis
2010
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
2005 Standout
Calcium Signaling
2007 Standout
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
2008
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
2003 Standout
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
2007
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects
2008
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans
1999
Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men
1998
Can antioxidant vitamins materially reduce oxidative damage in humans?
1999
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Oxidative Stress and Endothelial Nitric Oxide Bioactivity
2003
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel
2006
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
2014
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Sexually Dimorphic Response of the Balloon-Injured Rat Carotid Artery to Hormone Treatment
1997
Effects of Gonadal Steroids and Their Antagonists on DNA Synthesis in Human Vascular Cells
1998
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
2007
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
2010
Contrasting Effects of Conjugated Estrogens and Tamoxifen on Dilator Responses of Atherosclerotic Epicardial Coronary Arteries in Nonhuman Primates
1997
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β
2002 StandoutScienceNobel
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Stress-Related Cardiomyopathy Syndromes
2008
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets
2005
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel
2004
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
2010
Estradiol as an antioxidant: incompatible with its physiological concentrations and function
1998
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
2007
Metabolic reprogramming and cancer progression
2020 StandoutScience
Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Impairment of Endothelium-Dependent Vasodilation of Resistance Vessels in Patients With Obstructive Sleep Apnea
2000
Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis
2001
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and α-Tocopherol (Vitamin E)
2000
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
2009
Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
1996
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
2001
Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
1999
Vitamin E and vascular homeostasis: implications for atherosclerosis
1999
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
2005
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
2008
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Monitoring of Clopidogrel Action: Comparison of Methods
2005
Clopidogrel Response Variability and Future Therapies
2006
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults
2001
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Victor Guetta being referenced
One-year outcome following coronary angiography in elderly patients with non-ST elevation myocardial infarction
2012
Long-term Benefit of High-Density Lipoprotein Cholesterol–Raising Therapy With Bezafibrate
2009
Safety and Efficacy of the FilterWire EZ in Acute ST-Segment Elevation Myocardial Infarction
2007
Left ventricular apical ballooning: Not an uncommon variant of acute myocardial infarction in women
2006
Intracoronary Injection of In Situ Forming Alginate Hydrogel Reverses Left Ventricular Remodeling After Myocardial Infarction in Swine
2009
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
1997
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab
2002
Noninvasive assessment of left ventricular end-diastolic pressure by the response of the transmitral a-wave velocity to a standardized valsalva maneuver
2000
Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women
1995
Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial
2011
Deformation Dynamics and Mechanical Properties of the Aortic Annulus by 4-Dimensional Computed Tomography
2012
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)
2007
Coronary CT angiography for the detection of coronary artery stenosis in patients referred for transcatheter aortic valve replacement
2014
Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction
2003
The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement
2017
Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia
1994
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition
2004
Effects of the antiestrogen tamoxiten on low-density lipoprotein concentrations and oxidation in postmenopausal women
1995
Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
2011
Serial intravascular ultrasound evaluation of remodeling in transplant CAD: influence of disease progression
1998
Selective loss of microvascular endothelial function in human hypercholesterolemia.
1994
The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women
1997
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
2004
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction
2001
Relation Between Lesion Characteristics and Risk With Percutaneous Intervention in the Stent and Glycoprotein IIb/IIIa Era
1999
Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
2011
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
1996
Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis
1998